Atyr Pharma Inc (ATYR) returns
Atyr Pharma returns over 10 years
$1,000 invested in Atyr Pharma ten years ago was worth $3.15 at the close on October 30, 2026, with dividends reinvested: an average return of -43.8% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -59.2% | — | $407.59 | -0.9% |
| 3 months | -74.3% | — | $257.29 | +2.1% |
| Year to date | -84.2% | — | $157.71 | +11.7% |
| 1 year | -86.1% | — | $139.08 | +12.4% |
| 3 years | -90.1% | -53.8% | $98.80 | +88.5% |
| 5 years | -98.6% | -57.2% | $14.38 | +76.0% |
| 10 years | -99.7% | -43.8% | $3.15 | +316.6% |
Atyr Pharma return by calendar year
| Year | ATYR | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | -84.2% | +11.7% | -95.9% |
| 2025 | -78.4% | +17.7% | -96.1% |
| 2024 | +156.7% | +24.9% | +131.9% |
| 2023 | -35.6% | +26.2% | -61.8% |
| 2022 | -70.7% | -18.2% | -52.5% |
| 2021 | +92.5% | +28.7% | +63.8% |
| 2020 | -7.0% | +18.4% | -25.3% |
| 2019 | -39.9% | +31.2% | -71.1% |
| 2018 | -85.8% | -4.6% | -81.3% |
| 2017 | +62.8% | +21.7% | +41.1% |
| 2016 | -78.1% | +12.0% | -90.1% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: ATYR financials
No forecast, no recommendation. This page describes Atyr Pharma Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.